Monitor upcoming Q4 and full-year 2025 results for actual financials and formal guidance. The gap between asset value and market cap suggests potential for share repurchases or asset sales, which could catalyze re-rating.
Price Chart
Executive Summary
Cosmos Health provided a corporate update highlighting record revenue, a U.S. expansion with its NOOR brand projecting over $12M in annualized revenue, a $11.5M pharmacy network acquisition LOI, and non-core assets valued at over $18M. The company plans to issue updated guidance after its Q4 and full-year 2025 results, while evaluating share repurchases due to a perceived valuation disconnect.
Key Financial Metrics
Key Facts
- NOOR Collagen projected to generate over $12 million in annualized revenue in the U.S.
- Entered LOI to acquire a pharmacy distribution network generating $11.5 million in annual gross revenue.
- Non-core assets (real estate and digital) estimated at over $18 million in fair market value.
- Gross margins expected at approximately 75% for U.S. Sky Premium Life operations.
- Zacks initiated coverage with a $4.50 per share valuation, significantly above current market price.
- Management evaluating monetization of non-core assets and potential share repurchases.
Financial Impact
Non-core assets valued at >$18M vs. $12M market cap; potential for significant capital return or strategic use of proceeds.
Risk Factors
- Forward-looking statements dominate; no actual financials provided for 2025.
- Acquisition is only an LOI, not a binding agreement.
- Revenue projections ($12M NOOR, $11.5M pharmacy network) are estimates, not realized.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259321 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.2530 | awaiting T+20 | — | $0.2324 (−8.14%) |
Oct 16, 2026 10d ago | SC 13G/A | $0.3250 | awaiting T+20 | — | $0.2324 (−28.49%) |
Oct 9, 2026 17d ago | 8-K | $0.3496 | awaiting T+20 | — | $0.2324 (−33.52%) |
Sep 3, 2026 7w ago | Press Release | $0.2660 $0.4300 | ▼ −61.65% | ▼ −62.77% | $0.2324 (+12.63%) |
Aug 19, 2026 9w ago | Press Release | $0.1930 | awaiting T+20 | — | $0.2324 (−20.41%) |
Jul 20, 2026 14w ago | Press Release | $0.2303 $0.2050 | ▼ −10.99% | ▼ −15.11% | $0.2324 (+0.91%) |
Jul 17, 2026 14w ago | Press Release | $0.2348 $0.2179 | ▼ −7.20% | ▼ −11.64% | $0.2324 (−1.02%) |
Jul 16, 2026 14w ago | Press Release | $0.2807 $0.2065 | ▼ −26.43% | ▼ −30.05% | $0.2324 (−17.21%) |
Jul 15, 2026 14w ago | Press Release | $0.2785 $0.2071 | ▼ −25.64% | ▼ −27.98% | $0.2324 (−16.55%) |
Jul 14, 2026 14w ago | Press Release | $0.3071 $0.2198 | ▼ −28.43% | ▼ −30.92% | $0.2324 (−24.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers